Adiponectin can significantly inhibit the apoptosis of pancreatic cancer in vivo by decreasing the levels of the apoptotic marker cleaved-caspase 3 (Figure 1E). The gene discussed is ADIPOQ; the disease is familial pancreatic carcinoma.